Complete remission of metastatic renal cell carcinoma to the bone with sunitinib

Complete remission of metastatic renal cell carcinoma to the bone with sunitinib

Target agents such as tyrosine kinase inhibitors have improved renal cell carcinoma (RCC) patient outcomes. However, complete remission (CR) with target agents is rare. Furthermore, CR of bone metastasis is much less common. We report a case of CR in bone and lung metastatic RCC. Radical nephrectomy...

Full description

Bibliographic Details
Main Authors: Akihiro Yoshimura, Wataru Nakata, Gaku Yamamichi, Go Tsujimura, Yuichi Tsujimoto, Mikio Nin, Masao Tsujihata
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Urology Case Reports
Subjects:
Renal cell carcinoma
Bone metastasis
Sunitinib
Complete response
Online Access:http://www.sciencedirect.com/science/article/pii/S2214442020301017

Internet

http://www.sciencedirect.com/science/article/pii/S2214442020301017

Similar Items